Kimura Tomoyuki, Suzuki Shintaro, Kumaki Ryota, Kishimoto Keiko, Uno Tomoki, Nojo Makoto, Shimamura Miri, Iwazumi Eriko, Tanaka Akihiko, Sagara Hironori
Department of Medicine, Division of Allergology and Respiratory Medicine, School of Medicine, Showa University.
Division of Social Pharmacy, Department of Healthcare and Regulatory Sciences, School of Pharmacy, Showa University.
Arerugi. 2023;72(5):453-462. doi: 10.15036/arerugi.72.453.
BACKGROUND/PURPOSE: Anaphylactic shock is a serious and life-threatening condition, and affected patients should be quickly and effectively treated with an EpiPen. Although the correct use of an EpiPen is greatly affected by a user's proficiency level and the instructions accompanying the EpiPen, there has been almost no investigation into the knowledge of the EpiPen and the actual situation of the accompanying instructions for use. Therefore, we conducted this nationwide survey to elucidate these issues.
A questionnaire survey was conducted among pharmacists registered as members of the system of a research company outside the university and working at pharmacies with experience in handling EpiPen prescriptions.
Many of the pharmacists surveyed knew that the EpiPen is the first-line treatment for anaphylactic shock. However, they did not have sufficient knowledge of administration routes and candidates for second-line treatment. Both their occasions and experiences of dealing of EpiPen were found to be low.
It is desirable to learn at conferences regarding allergology/clinical allergy and seminars for medical professionals including pharmacists in order to acquire the skills and knowledge to consult with patients with allergic diseases, including action plans presented by doctors in preparation for recurrence of anaphylaxis.
背景/目的:过敏性休克是一种严重的、危及生命的病症,患病患者应使用肾上腺素笔进行快速有效的治疗。尽管肾上腺素笔的正确使用受到使用者熟练程度以及肾上腺素笔附带说明的极大影响,但几乎没有人对肾上腺素笔的知识以及附带使用说明的实际情况进行调查。因此,我们开展了这项全国性调查以阐明这些问题。
对注册为一家大学外研究公司系统成员且在有处理肾上腺素笔处方经验的药店工作的药剂师进行问卷调查。
许多接受调查的药剂师知道肾上腺素笔是过敏性休克的一线治疗方法。然而,他们对给药途径和二线治疗候选药物没有足够的了解。发现他们处理肾上腺素笔的场合和经验都很少。
希望通过参加过敏学/临床变态反应会议以及面向包括药剂师在内的医学专业人员的研讨会来学习,以获得与过敏性疾病患者咨询的技能和知识,包括医生为过敏性休克复发制定的行动计划。